DYNC1LI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.941560E-01
Normal-vs-Stage2
3.510400E-01
Normal-vs-Stage3
1.772160E-02
Normal-vs-Stage4
6.796600E-01
Stage1-vs-Stage2
7.276200E-01
Stage1-vs-Stage3
1.170780E-01
Stage1-vs-Stage4
8.278300E-02
Stage2-vs-Stage3
6.144300E-02
Stage2-vs-Stage4
1.747850E-01
Stage3-vs-Stage4
5.120400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.085000E-01
Normal-vs-AfricanAmerican
6.714600E-01
Normal-vs-Asian
3.142400E-01
Caucasian-vs-AfricanAmerican
7.407600E-01
Caucasian-vs-Asian
4.162200E-01
AfricanAmerican-vs-Asian
5.252000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.720600E-01
Normal-vs-Female
4.608800E-01
Male-vs-Female
3.464200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.613600E-01
Normal-vs-Age(41-60Yrs)
6.250600E-01
Normal-vs-Age(61-80Yrs)
3.488400E-01
Normal-vs-Age(81-100Yrs)
1.006830E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.827600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.546200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.057600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.545900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.732300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.399400E-01
Normal-vs-Daily Drinker
1.412150E-01
Normal-vs-Weekly Drinker
4.567000E-01
Normal-vs-Occasional Drinker
7.340600E-01
Normal-vs-Social Drinker
4.862200E-01
Non Drinker-vs-Daily Drinker
5.975800E-01
Non Drinker-vs-Weekly Drinker
5.598200E-01
Non Drinker-vs-Occasional Drinker
1.495770E-01
Non Drinker-vs-Social Drinker
4.589200E-01
Daily Drinker-vs-Weekly Drinker
3.253600E-01
Daily Drinker-vs-Occasional Drinker
7.254200E-02
Daily Drinker-vs-Social Drinker
2.516200E-01
Weekly Drinker-vs-Occasional Drinker
5.118000E-01
Weekly Drinker-vs-Social Drinker
9.105400E-01
Occasional Drinker-vs-Social Drinker
5.747000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.130200E-01
Normal-vs-Grade 2
8.776000E-01
Normal-vs-Grade 3
8.535200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.039400E-01
Grade 1-vs-Grade 3
4.107600E-01
Grade 1-vs-Grade 4
9.130200E-01
Grade 2-vs-Grade 3
5.524200E-01
Grade 2-vs-Grade 4
8.776000E-01
Grade 3-vs-Grade 4
8.535200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.980800E-01
Normal-vs-NonDiabetic
3.743600E-01
Diabetic-vs-NonDiabetic
6.714600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.982390E-01
Normal-vs-NoPancreatitis
3.940800E-01
Pancreatitis-vs-NoPancreatitis
6.366600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.751800E-01
Normal-vs-N1
3.639400E-01
N0-vs-N1
4.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.667400E-01
Normal-vs-TP53-NonMutant
4.763400E-01
TP53-Mutant-vs-TP53-NonMutant
4.134000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
